Back

06 January 2025

Masterclass: Antibiotics in decompensated liver disease, who, when and for how long

Sophia-and-Lynsey.PNG

This video covers the use of antibiotics in decompensated liver disease. We discuss the impact of bacterial infection in people with cirrhosis, evidence-based indications for antibiotic use, and the growing problem of anti-microbial resistance.


Biographies

Dr Lynsey Corless

Lynsey is a Consultant Hepatologist with a particular interest in decompensated disease and MASLD. She trained in Scotland and across Yorkshire, and am now based at Hull University Teaching Hospitals NHS Trust. She is a member of the BSG Liver Section Committee and the NIHR RDN National Specialty Lead for Gastroenterology & Hepatology.

Dr Sophia Than

Dr Nwe Ni Than is a consultant hepatologist working at the University Hospital Coventry NHS Trust. Her area of interest is managing patients with decompensated liver cirrhosis, metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma.